Cardiovascular API Supplier for South Korea — WHO GMP Certified

Aarise Pharmaceuticals exports WHO GMP certified cardiovascular APIs to South Korea (MFDS). We are a Haridwar, India-based API manufacturer supplying cardiovascular APIs including statins, calcium channel blockers, ARBs, and beta-blockers to pharmaceutical buyers in South Korea — Asia’s fourth-largest pharmaceutical market with strong generic drug demand.

Exporting Cardiovascular APIs to South Korea

MFDS registration required; WHO GMP certificate and Korean-language documentation accepted. Aarise Pharmaceuticals provides all required documentation — COA, MSDS, WHO GMP Certificate, COPP, DMF dossier, and Certificate of Origin — to facilitate smooth regulatory clearance for MFDS requirements.

Molecules Available for Export to South Korea

We supply the following cardiovascular APIs to South Korea: Atorvastatin, Rosuvastatin, Amlodipine, Losartan, Metoprolol. All molecules available in USP, BP, and IP grades at 98–99%+ purity. Additional molecules available on request.

Why South Korea Buyers Choose Aarise

• WHO GMP Certified — recognised by MFDS for bulk API imports
• MFDS-Ready Documentation — full regulatory dossier provided with every shipment
• NABL-Accredited QC — in-house analytical testing to pharmacopeial standards
• Competitive Pricing — direct manufacturer pricing, no middlemen
• Reliable Lead Times — 5–10 days standard; air freight available for urgent orders
• Dedicated Export Team — experienced in South Korea import compliance and logistics

Regulatory Documentation for South Korea

• Certificate of Analysis (COA) — batch-specific, signed by QC head
• WHO GMP Certificate — current, accepted by MFDS
• MSDS / SDS in GHS format
• Certificate of Pharmaceutical Product (COPP)
• DMF filing support for MFDS
• Certificate of Origin (for customs clearance in South Korea)

Shipping to South Korea

We ship cardiovascular APIs to South Korea via air freight (DHL, FedEx, UPS) and sea freight for large volume orders. Standard transit time: 3–7 days by air, 18–25 days by sea. We handle all export documentation including commercial invoice, packing list, COO, and pharma-grade shipping declarations.

Request a Quote for South Korea

To receive pricing, samples, or a regulatory documentation pack for cardiovascular API supply to South Korea, contact Aarise Pharmaceuticals at +91 9899783330. We respond within 24 hours.

Frequently Asked Questions

Can Aarise export cardiovascular APIs directly to South Korea?

Yes. Aarise Pharmaceuticals has active export experience to South Korea and can supply cardiovascular APIs with complete MFDS-compliant documentation including COA, WHO GMP certificate, and DMF support.

What documentation is required to import cardiovascular APIs into South Korea?

MFDS registration required; WHO GMP certificate and Korean-language documentation accepted. Aarise provides all required documents — COA, WHO GMP Certificate, COPP, MSDS, and Certificate of Origin — to support your import clearance.

What cardiovascular molecules are available for export to South Korea?

We supply Atorvastatin, Rosuvastatin, Amlodipine, Losartan, Metoprolol for export to South Korea. All molecules are available in USP/BP/IP pharmacopeial grade. Additional molecules available on request.

How long does delivery take from India to South Korea?

Air freight takes 3–7 business days from Haridwar to South Korea. Sea freight for large volumes takes 18–25 days. We dispatch samples within 3–5 business days of order confirmation.

Is there a minimum order for South Korea export?

MOQ starts from 100g for most cardiovascular APIs. Samples from 10–50g are available for development and regulatory filing. Contact us for volume pricing for commercial quantities.